ORCHARD THERAPEUTICS PLC-ADR (ORTX)       0.5  +0.02 (+4.87%)

0.5  +0.02 (+4.87%)

US68570P1012 - ADR - After market: 0.47 -0.03 (-6%)

Buy % Consensus

Analysts have set a mean price target of 3.74. This target is 648.01% above the current price.
ORTX was analyzed by 13 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about ORTX.
In the previous month the buy percentage consensus was at a similar level.
ORTX was analyzed by 13 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target

Price Low Median Mean High 0.501.014.593.745.25 - 102.00% 818.00% 648.01% 950.00%

Up and Down Grades

Date Firm Action Rating
2022-05-13 Barclays Maintains Overweight
2021-11-16 JP Morgan Downgrade Neutral -> Underweight
2021-11-05 Oppenheimer Maintains Outperform
2021-08-18 JP Morgan Downgrade Overweight -> Neutral

Analyst Ratings Stock Screener Links

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA